People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RefleXion Medical, Inc. | — | Healthtech | Series D+ | $413.0M | $1.3B | 2023 |
Jeffrey T. Holifield at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey T. Holifield on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nael Kassar | 1 | 11 |
| FRED MOLL | 1 | 8 |
| Greg Garfield | 1 | 8 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Jay Watkins | 1 | 6 |
| William Burkoth | 1 | 5 |
| Matthew Hobart | 1 | 4 |
| Colin Cahill | 1 | 2 |
| Alice Schroeder | 1 | 2 |
| Martyn Webster | 1 | 2 |
| Akshay Nanduri | 1 | 2 |
| David Larkin | 1 | 2 |
| Cem T. Usakli | 1 | 1 |
| Sean T. Shirvani | 1 | 1 |
| Diana J. King | 1 | 1 |
| Rana T. Al-Hallaq | 1 | 1 |
| Philip J. Aulson II | 1 | 1 |
| Art T. Heidrich | 1 | 1 |
| Martyn T. Webster | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.